(f) See responses to Item 6 of each cover page for each Reporting Person.
Item 3. | Source and Amount of Funds or Other Consideration. |
All of the shares of Common Stock reported herein as beneficially owned by the Reporting Persons were acquired pursuant to an Investment Agreement (the “Investment Agreement”), dated December 8, 2022, by and among the Issuer and WH Borrower, LLC. Pursuant to the Investment Agreement, on January 25, 2023, EXPWHP was issued 5,434,783 shares of Common Stock (the “Purchased Shares”) in a private placement at a purchase price of $4.60 per share (the “Private Placement”), or an aggregate purchase price of $25.0 million, financed with available cash from WHP Global.
Item 4. | Purpose of Transaction. |
The information set forth in or incorporated by reference in Item 3 and Item 6 of this Schedule 13D is hereby incorporated by reference in its entirety into this Item 4.
On December 8, 2022, the Issuer and WHP Global, a wholly-owned subsidiary of WH Borrower, LLC, announced that they had entered into a mutually transformative strategic partnership to advance an omnichannel platform which is expected to drive accelerated, long-term growth through the acquisition and operation of a portfolio of brands. The Issuer and WHP Global also formed an intellectual property joint venture intended to scale the Issuer’s brand through new domestic category licensing and international expansion opportunities. The intellectual property joint venture implies a total value of the Issuer brand’s intellectual property at approximately $400 million and will be 60% owned by WHP Global and 40% owned by the Issuer’s platform company. WHP Global will invest $235 million for its stake in the intellectual property joint venture and the Issuer will contribute certain of its intellectual property assets in exchange for cash consideration.
Under the terms of the transaction, WH Borrower made a common equity PIPE investment through EXPWHP to acquire 5.4 million newly issued shares of the Issuer at $4.60 per share. As further discussed in Item 6 below, pursuant to the Investment Agreement, WH Borrower has the right to designate and appoint one director to the Board (as defined in Item 6) and has designated and appointed one director to the Board. The Reporting Persons have also from time to time engaged in discussions with other shareholders of the Issuer and may, from time to time, continue to engage in discussions with members of management and the Board, other current or prospective shareholders, industry analysts, existing or potential strategic partners or competitors, investment and financing professionals, sources of credit and other third parties regarding a variety of matters relating to the Issuer, which may include, among other things, the Issuer’s business, management, capital structure and allocation, corporate governance, composition of the Board and strategic alternatives and direction, and may pursue other plans or proposals that relate to or could result in any of the matters set forth in clauses (a)-(j) of Item 4 of Schedule 13D.
The Reporting Persons expect to evaluate on an ongoing basis the Issuer’s financial condition and prospects and their respective interests in, and intentions with respect to, the Issuer and their respective investments in the securities of the Issuer, which review may be based on various factors, including the Issuer’s business and financial condition, results of operations and prospects, general economic and industry conditions, the securities markets in general and those for the Issuer’s securities in particular, as well as other developments and other investment opportunities. Accordingly, each Reporting Person reserves the right to change its intentions, as it deems appropriate. In particular, each Reporting Person may at any time and from time to time, in the open market, in privately negotiated transactions or otherwise, increase its holdings in the Issuer or dispose of all or a portion of the securities of the Issuer that the Reporting Persons now own or may hereafter acquire, subject to the Investment Agreement filed as an exhibit hereto.
Item 5. | Interest in Securities of the Issuer. |
(a)-(b) The information requested in these items is incorporated herein by reference from the cover pages of this Statement and the responses to Item 2 of this Statement. The following disclosure is based upon 68,306,959 shares of Common Stock of the Issuer issued and outstanding as of November 26, 2022, as set forth in the Issuer’s Quarterly Report on Form 10-Q, filed with the SEC on December 8, 2022.